Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by User2020on Dec 05, 2020 11:43am
111 Views
Post# 32043885

RE:RE:RE:RE:RE:RE:RE:Ceapro % Ownership

RE:RE:RE:RE:RE:RE:RE:Ceapro % Ownership
Ciao, I remember Ceapro back in the days when it was called Vexco, and at that time, they were doing the fractionation of grains and moved into oats.  They made oat powder for latex gloves and moved into the pet care products as well. From there, they started down the path of the early detection of diabetes and ran into a ton of money issues. Building the Sackatwen processing plant ($20M) and losing it.  (My recount of events could be a bit out of order)  At that point, I believe that when Dr. Redmond left and Gillies came on board.  The company was broke and had minimum revenue and had to re-invent itself.  If PGX didn't come along, the company would be nothing IMO.  This is where they started to focus on this single technology.  
 
What solidified my understanding and commitment to their strategy is when the cannabis crazy happen.  They didn't bite, sure if Gilles pumped up the stock like every other company in that space, and we could have seen a pop to $12 like Radient Tech, but look at them now trading at 0.10.   I don't think the company pursued cannabis as it would have distracted them from their game plan.  It wouldn't have gotten any farther ahead and would have to deal with the fallout and jeopardize everything.  Sure, I could have made a bit of money on that run, but I believe I can make close to the same or more if things play out.  What they are perusing is a lot bigger and has more market opportunities than a single market. 
 
Anyway, those are my thoughts, and I have been wrong before, and I've been correct.  
<< Previous
Bullboard Posts
Next >>